Case Study: QMS Re-Design Case Study
A highly diversified pharma company based outside Europe has grown by acquisition and as a consequence has developed a range of quality management systems (QMSs) and inherited a number of others. It consisted of a number of sites managed directly by the organization, and nearly 50 subsidiaries that were managing the sale of major products. These subsidiaries often used local contractors to manufacture other products for the local market only. Furthermore, the company strategy was to increasingly outsource more of its activities, with only a very few sites managed directly by the company. At the time of this project, there were nearly 300 external organizations across the company, directly involved in the development, manufacture, testing and distribution of the company’s products. So much diverse activity proved a
challenge for the global quality function.
How NSF Can Help You

What’s New with NSF

NSF Annual Review and Impact Report 2025 Now Live
April 20, 2026NSF has published its Annual Review and Impact Report 2025, detailing the organization’s progress over the past year and outlining strategic priorities for 2026.
Visit NSF at Making Pharma 2026
April 10, 2026Connect with our experts to discover how we help leading pharmaceutical and biotechnology companies achieve regulatory compliance and operational excellence.